IPIERIAN
We are using induced pluripotent stem cells for drug discovery and development. Focused on neurodegenerative diseases such as SMA, ALS and Parkinson's, and other major unmet medical needs.
IPIERIAN
Social Links:
Industry:
Biotechnology Health Care Medical Device
Founded:
2007-01-01
Address:
South San Francisco, California, United States
Country:
United States
Website Url:
http://www.ipierian.com
Total Employee:
11+
Status:
Closed
Contact:
650-872-4700
Email Addresses:
[email protected]
Total Funding:
80.67 M USD
Technology used in webpage:
IPv6 Cloudflare Cloudflare Hosting Cloudflare Network Error Logging Cloudflare DNS Cloudflare SSL LiteSpeed Drupal
Current Advisors List
Current Employees Featured
Founder
Acquisitions List
| Date | Company | Article | Price |
|---|---|---|---|
| 2009-07-08 | iZumi Bio | iZumi Bio acquired by iPierian | N/A |
Investors List
Mission BioCapital
Mission BioCapital investment in Venture Round - iPierian
Kleiner Perkins
Kleiner Perkins investment in Venture Round - iPierian
MPM Capital
MPM Capital investment in Venture Round - iPierian
SR One
SR One investment in Venture Round - iPierian
SR One
SR One investment in Series B - iPierian
Biogen Idec
Biogen Idec investment in Series B - iPierian
Highland Capital Partners
Highland Capital Partners investment in Series B - iPierian
ATEL Ventures
ATEL Ventures investment in Series B - iPierian
MPM Capital
MPM Capital investment in Series B - iPierian
GV
GV investment in Series B - iPierian
Official Site Inspections
http://www.ipierian.com
- Host name: 104.21.82.87
- IP address: 104.21.82.87
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "iPierian"
iPierian - Crunchbase Company Profile & Funding
IPierian is a drug discovery platform that develops therapies for neurodegenerative diseases such as SMA, ALS, and Parkinson’s. ... Products. Resources. Pricing. Resources. Log In. …See details»
iPierian Company Profile 2024: Valuation, Investors, Acquisition ...
IPierian General Information Description. Developer of therapies designed to treat neurodegenerative disease. The company engages in the research and development of …See details»
Investors | iPierian
IPierian is backed by Kleiner Perkins Caufield & Byers, Highland Capital Partners, MPM Capital, Google Ventures, SR One, FinTech Global Capital, Mitsubishi UFJ Capital, Biogen Idec New …See details»
About Us | iPierian
The monoclonal antibody development programs evolve from iPierian’s proprietary iPSC technology for disease modeling – utilizing patient-derived cortical neurons, motor neurons, …See details»
iPierian Company Profile | Management and Employees List
IPierian Profile and History. iPierian is a biotechnology company developing novel therapies for neurodegenerative disease, specifically focused on discovering monoclonal antibodies against …See details»
iPierian - Funding, Financials, Valuation & Investors - Crunchbase
IPierian is a drug discovery platform that develops therapies for neurodegenerative diseases such as SMA, ALS, and Parkinson’s. Search Crunchbase. ... How much funding has this …See details»
iPierian Overview | SignalHire Company Profile
To connect with iPierian employee register on SignalHire. Organization Website: ipierian.com : Social Links: Phone Number: 650-872-4700: iPierian industries Biotech: Headquarters …See details»
Leadership Team | iPierian
Adam Rosenthal, Ph.D., has served as iPierian’s Senior Director of Strategic and Corporate Development since August 2010, working across Finance, Business Development, R&D, and …See details»
iPierian - Products, Competitors, Financials, Employees, …
IPierian develops therapies to treat neurodegenerative diseases. The company discovers monoclonal antibodies against targets of the Tau protein for the treatment of Alzheimer's …See details»
iPierian - Crunchbase
IPierian is a drug discovery platform that develops therapies for neurodegenerative diseases such as SMA, ALS, and Parkinson’s. Search Crunchbase Start Free TrialSee details»
Ipierian - Company Profile - Tracxn
Nov 30, 2024 What are the most recent funding rounds of Ipierian? Its latest funding round was a Series C round on Sep 04, 2013 for $30M. 8 investors participated in its latest round, which …See details»
iPierian - VentureRadar
IPierian, Inc. is a biotechnology company developing novel therapies for neurodegenerative disease, specifically focused on discovering monoclonal antibodies against targets of the Tau …See details»
IPierian - Company Profile & Staff Directory - ContactOut
IPierian is a biotechnology company targeting secreted Tau for treatment of Alzheimer’s disease and other Tauopathies. The company’s lead drug candidate (IPN007) is a monoclonal …See details»
iPierian - Overview, News & Similar companies | ZoomInfo.com
IPierian. Manufacturing · California, United States · <25 Employees. iPierian is a biotechnology company developing novel therapies for neurodegenerative disease, specifically focused on …See details»
People | iPierian
To find out more about our team, please visit these pages: Leadership Team; Board of Directors; Scientific AdvisorsSee details»
iPierian - EquityNet
Prior to joining iPierian, Dr. was a Project Leader at the Boston Consulting Group, working with Fortune 500 pharmaceutical companies in the areas of R&D, operations, and corporate …See details»
[7 Steps] iPierian Case Study Solution - fernfortuniversity.com
Dec 3, 2024 This strategy leverages iPierian's core competencies in technology, content creation, and online learning platforms while navigating the competitive landscape of the …See details»
iPierian - Contacts, Employees, Board Members, Advisors & Alumni
Organization. iPierian . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies. Highlights. Employee Profiles 5. Number of Board …See details»
Home | iPierian
IPierian is a biopharmaceutical company creating a revolutionary new paradigm for drug discovery in neurodegenerative diseases Latest News. Congratulations to our SAB member Dr. Shinya …See details»
Isidore of Seville: the patron saint of the internet who shaped ...
1 hour ago Isidore of Seville preserved knowledge in the ‘Dark Ages’, earning him the title of patron saint of the internet. His work laid the groundwork for today’s world of shared information.See details»